SOL Group

SOL Group, founded in 1927 and listed on the Milan Stock Exchange since July of that year, operates within the Chemicals, Petrochemicals, Glass & Gases, and Manufacturing sectors. The company is actively engaged in the production, applied research, and sale of technical, pure, and medical gases. Its diversified portfolio also includes home care services, biotechnology, and renewable energy development, serving industries requiring specialized gas products and related services.

The group's operational scale is substantial, reporting $1.66 billion in revenue and employing between 5,000 and 10,000 individuals across its 3 locations. SOL Group's commitment to innovation is evident in applied research initiatives focused on enhancing product quality and developing new applications for its technical and medical gases. This R&D focus supports market leadership and the ability to meet evolving customer demands in critical sectors like healthcare and industrial manufacturing. Meet SOL Group's team to understand the expertise driving these operations.

SOL Group's product offerings include analytical services, field testing, and specialized products for clinical, human, animal, and medicinal use. The company also provides critical home care services, prioritizing patient monitoring and central functions. Its strategic focus on biotechnology and renewable energy underscores a commitment to sustainable practices and future growth. The company's extensive market presence positions it as a key player in its specialized industrial segments, consistently delivering technical solutions and services.